AzTrials
AzTrials

Laser Effect Around Dental ImplantNCT06666062

Evaluation of the Effect of Low Level Laser Therapy on Crestal Bone Changes and Secondary Stability Around Delayed Implant

A study testing implant placement and low level laser therapy and implant placement in people with Laser Effect Around Dental Implant, run by Lina Amr Talaat at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Although implant survival and success rates are prominent, there is still progress to be made in both survival and success rates, as well as in improving implant stability at implant placement in order to accomplish osseo-integration without significantly reducing peri-implant marginal bone. Read more about this study

Who is it for?
Ages 20 to 50 years
Conditions the study is for
Laser Effect Around Dental Implant
What is being tested?
implant placement and low level laser therapy and implant placement
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
24 participants
Where
1 siteEgypt
Study dates
1 Mar 2023to 1 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • 1- Healthy adult patients as evidenced by Burkett's oral medicine health history questionnaire (18).
  • 2- Both genders. 3- Age from 20 -50 years old. 4- History of extraction< 6 months. 5- Site specific upper esthetic zone from right second premolar to left second premolar.

Who cannot join

  • Patients taking drugs affecting bone metabolism for the past six months. eg. cyclosporine, methotrexate, synthetic retinoids
  • Smokers
  • Pregnancy and lactation
  • Patients with periodontal or periapical infections.
  • Vertical and horizontal root fracture
  • Mentally retarded Patients.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Ain shams university

    Cairo, 4531

Other trials in Egypt

About this study

Official title: " EVALUATION OF LOW INTENSITY LASER BIOMODULATORY EFFECT ON CRESTAL BONE CHANGES AROUND DELAYED IMPLANTS " A Randomized Controlled Clinical Trial

Although implant survival and success rates are prominent, there is still progress to be made in both survival and success rates, as well as in improving implant stability at implant placement in order to accomplish osseo-integration without significantly reducing peri-implant marginal bone. Low-level laser therapy (LLLT) has been postulated in studies looking into enhancing implant stability. Understanding the effect of LLLT on bone remodeling is crucial to knowing whether LLLT will enhance implant-bone interaction. LLLT prompts vascularization of the bone defect site and also stimulates osteoblasts, which can facilitate recovery of hard tissue. In addition, it has been recently reported that LLLT has positive effects in ossification and osseo-integration of dental implants.

Read the detailed description

This study will be conducted to evaluate the effects of LLLT on the crestal bone changes around dental implants.

Study Setting Faculty of Dentistry, Ain Shams University. Sample size : 24 patients are eligible to the study.

•statistical analysis : Categorical data will be represented as frequency (n) and percentage (%) and will be analyzed using chi square test. Numerical data will be explored for normality by checking the data distribution, calculating the mean and median values and using Kolmogorov-Smirnov and Shapiro-Wilk tests. If the data was found to be normal, it will be presented as mean and standard deviation values and independent t-test will be used for intergroup comparison. If the assumption of normality is violated, the data will be presented as median and range values and intergroup comparison will be done using Mann-Whitney U test and Freidman's test. The significance level will be set at P ≤0.05 for all tests. Statistical analysis will be performed with IBM® SPSS® Statistics Version 25 for Windows.

Inclusion Criteria:

  1. Healthy adult patients as evidenced by Burkett's oral medicine health history questionnaire (18).
  2. Both genders.
  3. Age from 20 -50 years old.
  4. History of extraction< 6 months.
  5. Site specific upper esthetic zone from right second premolar to left second premolar.

Exclusion criteria:

  1. Patients taking drugs affecting bone metabolism for the past six months. eg. cyclosporine, methotrexate, synthetic retinoids
  2. Smokers
  3. Pregnancy and lactation
  4. Patients with periodontal or periapical infections.
  5. Vertical and horizontal root fracture
  6. Mentally retarded Patients.

Study procedures:

  1. Randomization and allocation concealment technique: Patients will be randomly allocated according to predetermined computer-generated randomization using www.Randomizer.org
  2. Details of the interventions, testing and follow up:
  • Group A test: 10 patients will be subjected to delayed implant placement with Laser Biostimulation with Low Level Laser Therapy.
  • Group B control: 10 patients will be subjected to conventional delayed implant placement.

Study protocol and surgical steps

  1. Radiographs will be taken from all patients after an intraoral examination.
  2. Following the mucosal incision, the mucoperiosteal flap will be elevated.
  3. Drilling will be performed at 900 rpm in both groups. All implants will be placed with the same torque (60 rpm) by the same surgeon (15).
  4. All patients receive oral hygiene and post-operative care instructions. Group A: implant placement followed by laser bio- stimulation. Group B: implant placement without further intervention.

Low Level Laser Therapy Protocol:

Group A ( Test ):

In our study we applied a red diode laser (SmartM, Lasotronix, Poland) at 635 nm wavelength with biomodulating handpiece with following set parameters for the first session of LLLT output power: 100mW handpiece diameter: 2mm spot area: 0.0314cm2 average power density: 199.04mW/cm2 continuous mode, dose: 4J per point (16J/cm2) time: 10 sec per point, 4 points (irradiation on a buccal,lingual,mesial and distal side of the alveolus/implant), and total energy per session 16J Four irradiation sessions were provided with first therapy administered immediately following osteotomy and prior to implant placement and then immediately after implant placement , and then repeated on third day, seventh day, and fourteenth day after implant placement.

Parameters for the following sessions of LLLT :

output power: 100mW handpiece diameter: 8mm spot area: 0.5024cm2 average power density: 199.04mW/cm2 continuous mode, dose: 4J per point (16J/cm2) time: 10 sec per point, 4 points (irradiation on a buccal, lingual, mesial and distal side of the alveolus/implant), and total energy per session 16J

Group B (Control):

The same procedure was followed without laser application in this group.

Being tested
implant placement and low level laser therapy, implant placement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • implant placement and low level laser therapyOther

    Laser biomodulation with low level laser therapy around delayed implant

  • implant placementProcedure or surgery

    Delayed implant placement restoring missed tooth

Study groups in NCT06666062
Study groupRoleWhat they receive
Study groupActive comparatorNot described
Receives: Other: implant placement and low level laser therapy
Control groupPlacebo comparatorNot described
Receives: Procedure: implant placement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Radiographic evaluation of crestal bone changes

    Measured: 3 months

Secondary outcomes (1)
  1. Evaluation of the secondary implant stability using implant stability quotient ( ISQ ) in response to LLLT.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Oct 2024
  2. Study start1 Mar 2023
  3. Primary completion1 May 2024
  4. Study completion1 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06666062
Sponsor's protocol ID
1211
Status last verified
Oct 2024
First submitted
29 Oct 2024
Last updated
30 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing implant placement and low level laser therapy and implant placement in people with Laser Effect Around Dental Implant, run by Lina Amr Talaat at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Radiographic evaluation of crestal bone changes (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in